A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants.

Article English OPEN
RTS,S Clinical Trials Partnership; Agnandji, ST; Lell, B; Fernandes, JF; Abossolo, BP; Methogo, BG; Kabwende, AL; Adegnika, AA; Mordmüller, B; Issifou, S; Kremsner, PG; Sacarlal, J; Aide, P; Lanaspa, M; Aponte, JJ; Machevo, S; Acacio, S; Bulo, H; Sigauque, B; Macete, E; Alonso, P; Abdulla, S; Salim, N; Minja, R; Mpina, M; Ahmed, S; Ali, AM; Mtoro, AT; Hamad, AS; Mutani, P; ... view all 130 authors
(2012)
  • Publisher: Massachusetts Medical Society
  • Subject:
    mesheuropmc: parasitic diseases

: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.<br/> : We administer... View more
Share - Bookmark